Filtros : "Indexado na Base de Dados Scopus" "Diniz, Gabriela Placoná" Removido: "Abstracts" Limpar

Filtros



Refine with date range


  • Source: Clinical Science. Unidade: ICB

    Subjects: ANATOMIA, FISIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná et al. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy. Clinical Science, v. 131, n. 24, p. 2885-2900, 2017Tradução . . Disponível em: https://doi.org/10.1042/CS20171368. Acesso em: 01 nov. 2024.
    • APA

      Diniz, G. P., Huang, Z. -P., Liu, J., Chen, J., Ding, J., Fonseca, R. I., et al. (2017). Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy. Clinical Science, 131( 24), 2885-2900. doi:10.1042/CS20171368
    • NLM

      Diniz GP, Huang Z-P, Liu J, Chen J, Ding J, Fonseca RI, Barreto-Chaves MLM, Donato Junior J, Hu X, Wang D-Z. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy [Internet]. Clinical Science. 2017 ; 131( 24): 2885-2900.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1042/CS20171368
    • Vancouver

      Diniz GP, Huang Z-P, Liu J, Chen J, Ding J, Fonseca RI, Barreto-Chaves MLM, Donato Junior J, Hu X, Wang D-Z. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy [Internet]. Clinical Science. 2017 ; 131( 24): 2885-2900.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1042/CS20171368
  • Source: Vascular Pharmacology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARRETO-CHAVES, Maria Luiza Morais et al. The crosstalk between thyroid hormones and the Renin–Angiotensin System. Vascular Pharmacology, v. 52, n. 3-4, p. 166-170, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2009.10.009. Acesso em: 01 nov. 2024.
    • APA

      Barreto-Chaves, M. L. M., Carrillo-Sepúlveda, M. A., Carneiro-Ramos, M. S., Gomes, D. A., & Diniz, G. P. (2010). The crosstalk between thyroid hormones and the Renin–Angiotensin System. Vascular Pharmacology, 52( 3-4), 166-170. doi:10.1016/j.vph.2009.10.009
    • NLM

      Barreto-Chaves MLM, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. The crosstalk between thyroid hormones and the Renin–Angiotensin System [Internet]. Vascular Pharmacology. 2010 ; 52( 3-4): 166-170.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.vph.2009.10.009
    • Vancouver

      Barreto-Chaves MLM, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. The crosstalk between thyroid hormones and the Renin–Angiotensin System [Internet]. Vascular Pharmacology. 2010 ; 52( 3-4): 166-170.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.vph.2009.10.009
  • Source: Basic Research in Cardiology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARNEIRO-RAMOS, M. S. et al. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Research in Cardiology, v. 105, n. 3, p. 325-35, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00395-010-0089-0. Acesso em: 01 nov. 2024.
    • APA

      Carneiro-Ramos, M. S., Diniz, G. P., Nadu, A. P., Almeida, J., Vieira, R. L. P., Santos, R. A. S., & Barreto-Chaves, M. L. M. (2010). Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Research in Cardiology, 105( 3), 325-35. doi:10.1007/s00395-010-0089-0
    • NLM

      Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RLP, Santos RAS, Barreto-Chaves MLM. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation [Internet]. Basic Research in Cardiology. 2010 ; 105( 3): 325-35.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00395-010-0089-0
    • Vancouver

      Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RLP, Santos RAS, Barreto-Chaves MLM. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation [Internet]. Basic Research in Cardiology. 2010 ; 105( 3): 325-35.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00395-010-0089-0

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024